Wall Street analysts will be watching closely when The Chemours Company (NYSE:CC) reports its quarterly earnings next, which is scheduled for Wed 13 Feb (In 31 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $1.65 per share. In the preceding quarter, the company reportedly generated EPS of $1.49 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 18.60%, a profit margin of 16.00% and a gross margin of 30.50%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of The Chemours Company (NYSE:CC). Most recently, on January 8th, 2019, HSBC Securities Initiated a Buy rating. Before that, on January 4th, 2019, Citigroup Upgrade to Buy. Citigroup Downgrade a Neutral rating on November 2nd, 2018, RBC Capital Mkts Initiated an Outperform rating on July 18th, 2018, and Morgan Stanley Initiated a Equal-Weight rating on January 30th, 2018.
At its current price point, combined with the fact that this company has 169.82M shares outstanding, the current market capitalization sits at 5.75B. In the last trading day, 1,331,267 shares of The Chemours Company were traded, which compares to its usual volume of about 2.05M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $2.77 in the past five trading days, resulting in a percentage change of +8.92% and a moving average of 33.08. In the past 20 days, its price changed by $7.19 (which is +26.98%) and the stock’s moving average was 29.02. Looking back a full 50 days, shares of CC changed by $1.43 (which is +4.41%) and demonstrated a moving average of 29.64.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 93.04%, a 14-day Stochastic %K score of 94.28% and a 20-day Stochastic %K score of 94.34%. Using a similar metric, The Chemours Company (CC) shares showed a Stochastic %D of 92.91% over the past 9 days, a Stochastic %D score of 93.70% over the last 14 days, and a 20-day Stochastic %D of 93.81%. Meanwhile, this stock’s MACD Oscillator was 2.02 over the past 9 days, 3.60 over the past two weeks, and 4.42 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $33.84 level. Over the past 12 months, this stock has experienced a high price of $54.62 and a low of $25.17. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
Fidelity Management Research Co purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from The Chemours Company (NYSE:CC) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 24,898,794 shares of the company’s stock following the addition of 2,021,678 to this investor’s holdings during the three-month period. This share count represents that Fidelity Management Research Co now held 14.55% stake in The Chemours Company (CC)’s shares.
Just in the most recent trading day, The Chemours Company (NYSE:CC) experienced a high price of $34.37 and low point of $33.35. At the end of the last trading session, this stock was at 33.84 per share, following a loss of -$0.16, or 0.74% during the full day.